Steve Mertens
2021
In 2021, Steve Mertens earned a total compensation of $371.1K as Chief Technology Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $56,338 |
|---|---|
| Option Awards | $72,169 |
| Salary | $242,631 |
| Total | $371,138 |
Mertens received $242.6K in salary, accounting for 65% of the total pay in 2021.
Mertens also received $56.3K in non-equity incentive plan and $72.2K in option awards.
Rankings
In 2021, Steve Mertens' compensation ranked 11,287th out of 12,405 executives tracked by ExecPay. In other words, Mertens earned more than 9.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,287 out of 12,405 | 9th |
Division Manufacturing | 4,983 out of 5,494 | 9th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 698 out of 798 | 13th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 457 out of 519 | 12th |
Industry Surgical and Medical Instruments and Apparatus | 288 out of 324 | 11th |
Source: SEC filing on April 29, 2022.
Mertens' colleagues
We found two more compensation records of executives who worked with Steve Mertens at NEUROONE MEDICAL TECHNOLOGIES Corp in 2021.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021